September 8, 2020

Blueprint to Biogen: A map for Selling to Biogen

In the latest edition of Sponsor Atlas: Selling to the Pharma Giants, we're looking at Biogen.

April 1, 2020

Guide to Gilead: A map for Selling to Gilead Sciences

In this edition of Sponsor Atlas: Selling to the Pharma Giants, we're looking at Gilead Sciences. Learn more about their top products, decision making, outsourcing history, and more!

March 2, 2020

Finding Pfizer: A map for Selling to Pfizer

In the latest edition of Sponsor Atlas: Selling to the Pharma Giants, we're looking at one of the biggest! Learn more about Pfizer's outsourcing history, top products, decision making, and more.

March 2, 2020

Activating Amgen: A map for Selling to Amgen

Thousand Oaks' Amgen Inc. is next up in the Sponsor Atlas: Selling to the Pharma Giants series. Check it out!

February 24, 2020

Accessing Allergan: A map for Selling to Allergan

In the latest edition of Sponsor Atlas: Selling to the Pharma Giants, we're looking at the outsourcing, decision making, and product information for Allergan

September 30, 2020

All About AbbVie: A map for Selling to AbbVie

Sponsor Atlas: Selling to the Pharma Giants is back! Chicago's AbbVie has become one of big pharma's dynamic powerhouses since being spun out from Abbott, and we're excited to take a look at their outsourcing, decision making, and innovation histories!

February 18, 2020

Mapping Merck: A map for Selling to Merck & Co.

Merck & Co. is an American pharmaceutical company, ranked 4th internationally in the world in terms of 2017 prescription sales [1]. It is important to note that Merck & Co. is a wholly separate and independent company from the German company Merck KGaA, despite the fact that the two share a common origin and brand name.

October 15, 2019

Anything but Generic: A map for Selling to Teva Pharmaceuticals

The latest edition of the Sponsor Atlas series takes a look at Israel's generics giant, Teva Pharmaceuticals.

October 14, 2019

Navigating Novo: A Map for Selling to Novo Nordisk

Born from the 1989 merger between Denmark’s top two insulin producers, Novo Nordisk markets products to over 165 countries. Learn how and where they make decisions about outsourcing activities in clinical research, contract manufacturing, logistics, and more.

October 15, 2019

From A to Z: A map for Selling to AstraZeneca

The latest edition of our Sponsor Atlas: Selling to the Pharma Giants series, where we are taking a look at AstraZeneca.

March 4, 2020

Breaking into Bristol, Myers, AND Squibb: A map for Selling to Bristol-Myers Squibb

In this edition of Sponsor Atlas: Selling to the Pharma Giants, we're visiting New York City's biopharma behemoth, Bristol-Myers Squibb (BMS). Their three-part name was born in 1989 merger between the Squibb Corporation and the Bristol-Myers Corporation, two NYC-based pharmaceutical companies founded in 1858 and 1887, respectively.

October 14, 2019

Started From Aspirin™, Now They’re Here: A map for Selling to Bayer

Part 2 of our Sponsor Atlas: Selling to the Pharma Giants blog series. It's off to Germany for the latest stop on our expedition, to visit Bayer and understand how they make their outsourcing decisions and how best to find opportunities.

October 15, 2019

Can I still cold email European pharma companies under GDPR?

A guide to GDPR for service provider companies selling to pharmaceutical & biotech companies in Europe. With strict new regulations being implemented, how can you reach your potential customers?

March 13, 2020

Decisions, Decisions: A map for Selling to Novartis

Multinational giants like Novartis can be a tough sell for service provider companies when they don't know where to target. Understanding where decisions about different kinds of outsourced activities take place can help you close more new business. Join us for part one of our new series Sponsor Atlas: Selling to the Pharma Giants!